SCYNEXIS, Inc. Earnings Per Share (Basic)
SCYNEXIS, Inc. (SCYX) reported Earnings Per Share (Basic) of $0.63 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- SCYNEXIS, Inc. earnings per share, basic for the quarter ending 2026-06-30 was $0.63.
- SCYNEXIS, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.42.
- SCYNEXIS, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.17.
- SCYNEXIS, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$1.11.
- SCYNEXIS, Inc. earnings per share, basic for fiscal 2025 was -$0.17.
- SCYNEXIS, Inc. earnings per share, basic for fiscal 2024 was -$0.44, a 131.43% decline from fiscal 2023.
- SCYNEXIS, Inc. earnings per share, basic for fiscal 2023 was $1.40.
- SCYNEXIS, Inc. earnings per share, basic for fiscal 2022 was -$1.47.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.63 10-Q · filed 2026-08-10 | -$1.53 10-Q · filed 2026-08-10 | |||||
| 2026-03-31 | -$0.42 10-Q · filed 2026-05-11 | ||||||
| 2025-12-31 | -$0.17 10-K · filed 2026-03-04 | ||||||
| 2025-09-30 | -$0.17 10-Q · filed 2025-11-05 | -$0.42 10-Q · filed 2025-11-05 | |||||
| 2025-06-30 | -$1.11 10-Q · filed 2026-08-10 | -$0.14 10-Q · filed 2025-08-13 | -$1.98 10-Q · filed 2026-08-10 | -$0.25 10-Q · filed 2025-08-13 | |||
| 2025-03-31 | -$0.11 10-Q · filed 2026-05-11 | ||||||
| 2024-12-31 | -$0.44 10-K · filed 2026-03-04 | ||||||
| 2024-09-30 | -$0.06 10-Q · filed 2025-11-05 | -$0.35 10-Q · filed 2025-11-05 | |||||
| 2024-06-30 | -$0.30 10-Q · filed 2025-08-13 | -$0.29 10-Q · filed 2025-08-13 | |||||
| 2024-03-31 | $0.01 10-Q · filed 2025-05-15 | ||||||
| 2023-12-31 | $1.40 10-K · filed 2025-03-12 | ||||||
| 2023-09-30 | -$0.04 10-Q · filed 2024-11-06 | $1.81 10-Q · filed 2024-11-06 | |||||
| 2023-06-30 | $2.56 10-Q · filed 2024-08-08 | $1.85 10-Q · filed 2024-08-08 | |||||
| 2023-03-31 | -$0.71 10-Q · filed 2024-05-08 | ||||||
| 2022-12-31 | -$1.47 10-K · filed 2024-03-28 | ||||||
| 2022-09-30 | -$0.62 10-Q · filed 2023-11-13 | -$1.18 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | -$0.31 10-Q · filed 2023-08-14 | -$0.50 10-Q · filed 2023-08-14 | |||||
| 2022-03-31 | -$0.17 10-Q · filed 2023-05-10 | ||||||
| 2021-12-31 | -$1.25 10-K · filed 2023-03-31 | ||||||
| 2021-09-30 | -$0.02 10-Q · filed 2022-11-09 | -$0.14 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | $0.06 10-Q · filed 2022-08-15 | -$0.12 10-Q · filed 2022-08-15 | |||||
| 2021-03-31 | -$0.18 10-Q · filed 2022-05-12 | ||||||
| 2020-09-30 | $0.09 10-Q · filed 2021-11-10 | -$1.23 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | -$0.64 10-Q · filed 2021-08-16 | -$1.35 10-Q · filed 2021-08-16 | |||||
| 2020-03-31 | -$0.72 10-Q · filed 2021-05-17 | ||||||
| 2019-09-30 | -$1.43 10-Q · filed 2020-11-06 | -$0.14 10-Q · filed 2019-11-12 | -$7.44 10-Q · filed 2020-11-06 | -$0.74 10-Q · filed 2019-11-12 | |||
| 2018-09-30 | $0.01 10-Q · filed 2019-11-12 | -$0.34 10-Q · filed 2019-11-12 | |||||
| 2018-03-31 | -$0.12 10-Q · filed 2018-05-08 | ||||||
| 2017-09-30 | -$0.31 10-Q · filed 2018-11-13 | -$0.67 10-Q · filed 2018-11-13 | |||||
| 2017-03-31 | -$0.19 10-Q · filed 2018-05-08 | ||||||
| 2016-12-31 | -$1.58 10-K · filed 2017-03-13 | ||||||
| 2016-06-30 | -$0.56 10-Q · filed 2016-08-08 | -$1.07 10-Q · filed 2016-08-08 | |||||
| 2016-03-31 | -$0.52 10-Q · filed 2017-05-08 | ||||||
| 2015-12-31 | -$0.60 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$1.20 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$1.96 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$2.68 10-K · filed 2017-03-13 | |||
| 2015-09-30 | -$0.60 10-Q · filed 2015-11-13 | -$1.37 derived: net income ÷ weighted average shares · filed 2015-11-13 | -$2.09 10-Q · filed 2015-11-13 | -$2.53 derived: net income ÷ weighted average shares · filed 2017-03-13 | |||
| 2015-06-30 | -$0.78 10-Q · filed 2016-08-08 | -$1.53 10-Q · filed 2016-08-08 | -$1.94 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$2.41 derived: net income ÷ weighted average shares · filed 2017-03-13 | |||
| 2015-03-31 | -$0.75 10-Q · filed 2016-05-09 | -$1.11 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$1.56 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$1.47 derived: net income ÷ weighted average shares · filed 2017-03-13 | |||
| 2014-12-31 | -$0.36 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$0.81 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$0.66 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$1.04 10-K · filed 2017-03-13 | |||
| 2014-09-30 | -$0.45 10-Q · filed 2015-11-13 | -$0.27 derived: net income ÷ weighted average shares · filed 2015-11-13 | -$0.59 10-Q · filed 2015-11-13 | -$11.46 derived: net income ÷ weighted average shares · filed 2015-11-13 | |||
| 2014-06-30 | $0.38 10-Q · filed 2015-08-19 | $0.26 10-Q · filed 2015-08-19 | -$19.14 derived: net income ÷ weighted average shares · filed 2015-10-30 | -$26.70 derived: net income ÷ weighted average shares · filed 2015-10-30 | |||
| 2014-03-31 | -$3.65 8-K · filed 2015-10-30 | -$117.53 derived: net income ÷ weighted average shares · filed 2015-10-30 | -$129.17 derived: net income ÷ weighted average shares · filed 2015-10-30 | -$137.14 derived: net income ÷ weighted average shares · filed 2015-10-30 | |||
| 2013-12-31 | -$113.78 derived: net income ÷ weighted average shares · filed 2015-10-30 | -$125.37 derived: net income ÷ weighted average shares · filed 2015-10-30 | -$133.36 derived: net income ÷ weighted average shares · filed 2015-10-30 | -$139.47 8-K · filed 2015-10-30 | |||
| 2013-09-30 | -$11.79 10-Q · filed 2014-11-13 | -$19.84 derived: net income ÷ weighted average shares · filed 2014-11-13 | -$25.99 10-Q · filed 2014-11-13 | ||||
| 2013-06-30 | -$8.05 10-Q · filed 2014-08-13 | -$14.21 10-Q · filed 2014-08-13 | |||||
| 2013-03-31 | -$6.16 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |